Cipla inks licensing deal with Belgium's MultiG for distribution of COVID-19 antibody test kit

"As part of this agreement, Cipla will be responsible for distribution of the COVID-19 rapid antibody kit that will be manufactured by MultiG" the company added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kFJF0R
via IFTTT

0 comments:

Post a Comment